# Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus

> **NCT03025906** · PHASE2 · UNKNOWN · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 120 (estimated)

## Conditions studied

- Generalized Convulsive Status Epilepticus

## Interventions

- **DRUG:** Phenobarbital
- **DRUG:** Valproate

## Key facts

- **NCT ID:** NCT03025906
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-16
- **Primary completion:** 2019-10
- **Final completion:** 2019-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2019-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03025906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03025906, "Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03025906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*